Yan Min Tang
Director/Board Member at SINOCELLTECH GROUP LIMITED
Yan Min Tang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SINOCELLTECH GROUP LIMITED | Director/Board Member | 11/07/2017 | - |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Director/Board Member | 21/08/2018 | - |
| ABBISKO CAYMAN LIMITED | Director/Board Member | 09/06/2021 | - |
| SINO BIOLOGICAL,INC. | Director/Board Member | 31/03/2018 | - |
Beijing Sinotau Pharmaceutical Technology Co., Ltd.
 Beijing Sinotau Pharmaceutical Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sinotau Pharmaceuticals Group, Beijing Sinotau Pharmaceutical Technology Co., Ltd. is a company founded in 2005 that engages in research & development, manufacture and promotion of radiopharmaceuticals and biological antibody drugs. The company is based in Beijing, China. | Director/Board Member | 30/04/2016 | - |
| President | 30/04/2016 | - | |
Qiming Venture Partners Ltd.
 Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China. | Private Equity Investor | - | - |
| Guangdong Xiantong Molecular Imaging Technology Co. Ltd. | Director/Board Member | 31/08/2020 | - |
| Suzhou Keyue Biotech Co. Ltd. | Director/Board Member | 30/09/2018 | - |
Suzhou Cure Genetics Co., Ltd.
 Suzhou Cure Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Cure Genetics Co., Ltd. is a biotechnology company based in Suzhou, China. The Chinese company specializes in developing gene and cell therapy for tumors and genetic diseases. | Director/Board Member | 30/06/2018 | - |
| ░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ | - | - |
Career history of Yan Min Tang
Former positions of Yan Min Tang
| Companies | Position | Start | End |
|---|---|---|---|
| ░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Yan Min Tang
| Shenyang Pharmaceutical University | Undergraduate Degree |
| Cheung Kong Graduate School of Business | Masters Business Admin |
Statistics
International
| China | 16 |
| Hong Kong | 2 |
| Cayman Islands | 2 |
Operational
| Director/Board Member | 12 |
| President | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 8 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| SINOCELLTECH GROUP LIMITED | Commercial Services |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
| ABBISKO CAYMAN LIMITED | Health Technology |
| SINO BIOLOGICAL,INC. | Health Technology |
| Private companies | 11 |
|---|---|
| Suzhou Qiyuan Equity Investment Mgmt Partnership Enterprise LP | |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
Beijing Jiakesi New Drug Development Co. Ltd.
 Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Jiakesi New Drug Development Co. Ltd. develops and sells drugs. The company was founded by Yinxiang Wang on July 17, 2015 and is headquartered in Beijing, China. | Health Technology |
| Jacobio Hk Pharmaceuticals Co. Ltd. | |
| Asia Baokang Pharmaceutical Consulting Beijing Co. Ltd. | |
Suzhou Cure Genetics Co., Ltd.
Suzhou Cure Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Cure Genetics Co., Ltd. is a biotechnology company based in Suzhou, China. The Chinese company specializes in developing gene and cell therapy for tumors and genetic diseases. | Health Technology |
Beijing Sinotau Pharmaceutical Technology Co., Ltd.
Beijing Sinotau Pharmaceutical Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sinotau Pharmaceuticals Group, Beijing Sinotau Pharmaceutical Technology Co., Ltd. is a company founded in 2005 that engages in research & development, manufacture and promotion of radiopharmaceuticals and biological antibody drugs. The company is based in Beijing, China. | Commercial Services |
| Suzhou Keyue Biotech Co. Ltd. | |
| Guangdong Xiantong Molecular Imaging Technology Co. Ltd. | |
Qiming Venture Partners Ltd.
Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China. | Finance |
Sinotau Pharmaceuticals Group
 Sinotau Pharmaceuticals Group Pharmaceuticals: MajorHealth Technology Sinotau Pharmaceuticals Group is a Chinese pharmaceutical company founded in 2005 that focuses on becoming an overall solution provider in the field of neurological degenerative lesions. The company is based in Beijing, China, and has subsidiaries in China. The company offers a range of products and services, including nuclear medicine, radioactive drug development, high-quality production, and clinical academic promotion. The company has a drug research and development technology platform and monoclonal antibody research and development drug technology platform, supplemented by generic drug research and development, production, and sales. The company also offers targeted drugs, precise diagnosis, and precision therapy drugs guided by research, development, and commercial molecular images. | Health Technology |
- Stock Market
- Insiders
- Yan Min Tang
- Experience
